Lobe Sciences Commences Engineering of Nasal Mist Device
Lobe Sciences Ltd. (“Lobe” or the “Company”) (CSE:LOBE) (OTC Pink: GTSIF) is pleased to announce that it has engaged VisionWorks Engineering of SanDiego, CA to commence engineering work to complete and test a proof of concept prototype of its nasal mist device.
This is a major milestone towards the ultimate goal for development of effective delivery methods and commercialization. The Company holds several provisional patent applications including for a nasal mist
device entitled “Device and Method for the Treatment of Traumatic Brain Injuries and Post-Traumatic Stress
Disorder”. This device includes a nasal delivery system for administration of pharmaceutical agents such as
a psilocybin-derived agent and/or N-acetylcysteine (“NAC”) at preselected dosages and times. The device
design allows for the precise control and delivery of medicines through the nasal cavity for faster and more
efficient uptake of psychedelics and other medicines that target the brain.
Tom Baird, CEO of Lobe states “The development and advancement of this innovative device will put us at
the forefront of delivering effective therapeutics to millions of people who suffer from mild traumatic brain
injury, post-traumatic stress disorder and other mental health issues. Development of this device will
reimagine the future for PTSD sufferers and radically change the limited treatment options for people who
suffer from mTBI and PTSD. We are excited with the progress being made as we pursue our research
initiatives including the recent launch of preclinical studies with the University of Miami’s Miller School of
Paul Seiter, CEO of VisionWorks, said “This is a great opportunity for LOBE and VisionWorks to develop a device that could dramatically improve the delivery of drugs for brain related therapies. We are excited to work with the Lobe team to bring this device to the market.”
About Lobe Sciences Ltd.
Lobe is a growth-oriented research, technology & services company that provides financial, management, IP
and branding support to businesses. The Company operates a portfolio of companies focused on developing
transformational medicines and applies refined strategies to help partner companies reach their full potential.
Based in Vancouver, BC, Lobe Sciences creates value through acquisitions and development of assets,
products and technologies by leveraging its scientific, engineering, branding and operational expertise
supported by strong capital markets acumen.